OpenAI Acquires AI Biotech Startup Orchestra Bio to Expand Life Sciences Tools
OpenAI will integrate Orchestra Bio’s AI agents for drug-discovery operations into Rosalind and Rosalind Workbench, tools for planning experiments and analyzing results. The four-year-old startup had raised about $20 million; Moderna and Novo Nordisk are Rosalind customers.